GSK has been giving Relenza to China for decades, part of a sweet deal to sell flu vaccine. Shareholders got nothing(of course) and Biota management probably had no control (as usual).
china relenza study, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)